Gene · 53345
Papers1,658
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 1,658
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| GPAT1 Deficiency in Mice Modulates NASH Progression in a Model-Dependent Manner. | Cell Mol Gastroenterol Hepatol | 2024 | 37844795 | PubTator, text mining | PubMed |
Taiwan Association for the Study of the Liver-Taiwan Society of Cardiology Taiwan position statement for the management of metabolic dysfunction- associated fatty liver disease and cardiovascular diseases. | Clin Mol Hepatol | 2024 | 37793641 | PubTator, text mining | PubMed |
| Impact of genetic polymorphism on personalized diet and exercise program for steatotic liver disease. | Hepatol Res | 2024 | 37715600 | PubTator, text mining | PubMed |
| Genetic and Metabolic Characteristics of Lean Nonalcoholic Fatty Liver Disease in a Korean Health Examinee Cohort. | Gut Liver | 2024 | 37560798 | PubTator, text mining | PubMed |
| No association of NAFLD-related polymorphisms in PNPLA3 and TM6SF2 with all-cause and cardiovascular mortality in an Austrian population study. | Wien Klin Wochenschr | 2024 | 37103556 | PubTator, text mining | PubMed |
| Regional variation in NAFLD prevalence and risk factors among people living with HIV in Europe: a meta-analysis. | Front Public Health | 2023 | 38259755 | PubTator, text mining | PubMed |
| Human Induced Pluripotent Stem Cell based Hepatic-Modeling of Lipid metabolism associated TM6SF2 E167K variant. | bioRxiv | 2023 | 38187603 | PubTator, text mining | PubMed |
| Association of MBOAT7 rs641738 polymorphism with hepatocellular carcinoma susceptibility: A systematic review and meta-analysis. | World J Gastrointest Oncol | 2023 | 38173430 | PubTator, text mining | PubMed |
| Association of Metabolic Dysfunction-Associated Fatty Liver Disease With Risk of HF and AF. | JACC Asia | 2023 | 38155795 | PubTator, text mining | PubMed |
| Causal effects of non-alcoholic fatty liver disease on osteoporosis: a Mendelian randomization study. | Front Endocrinol (Lausanne) | 2023 | 38149094 | PubTator, text mining | PubMed |
| Contrasting effects of whole-body and hepatocyte-specific deletion of the RNA polymerase III repressor Maf1 in the mouse. | Front Mol Biosci | 2023 | 38143800 | PubTator, text mining | PubMed |
| Case-control analysis of venous thromboembolism risk in non-alcoholic steatohepatitis diagnosed by transient elastography. | World J Clin Cases | 2023 | 38130793 | PubTator, text mining | PubMed |
| Surveillance for hepatocellular carcinoma in non-alcoholic fatty liver disease patients: towards personalized risk stratification. | Hepatobiliary Surg Nutr | 2023 | 38115941 | PubTator, text mining | PubMed |
| Metabolic dysfunction-associated fatty liver disease and hepatocellular carcinoma: present and future. | Hepatobiliary Surg Nutr | 2023 | 38115940 | PubTator, text mining | PubMed |
| Unmasking the enigma of lipid metabolism in metabolic dysfunction-associated steatotic liver disease: from mechanism to the clinic. | Front Med (Lausanne) | 2023 | 38089874 | PubTator, text mining | PubMed |
| Transcriptomics of MASLD Pathobiology in African American Patients in the Washington DC Area †. | Int J Mol Sci | 2023 | 38068980 | PubTator, text mining | PubMed |
| Prevalence and Risk Factors of MASLD and Liver Fibrosis amongst the Penitentiary Population in Catalonia: The PRISONAFLD Study. | J Clin Med | 2023 | 38068330 | PubTator, text mining | PubMed |
| Clinical characterization and proteomic profiling of lean nonalcoholic fatty liver disease. | Front Endocrinol (Lausanne) | 2023 | 38034020 | PubTator, text mining | PubMed |
| Molecular genetics of neuropsychiatric illness: some musings. | Front Genet | 2023 | 38028602 | PubTator, text mining | PubMed |
| High-frequency variants in PKA signaling-related genes within a large pediatric cohort with obesity or metabolic abnormalities. | Front Endocrinol (Lausanne) | 2023 | 38027204 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/53345/papers?page=12